FDA clears exoskeleton for stroke rehabilitation

FDA clears exoskeleton for stroke rehabilitation

By Excelsio Media on January 23, 2023 Also in fda, science

The U.S. Food and Drug Administration has cleared Wandercraft's self-balancing exoskeleton for use in stroke rehabilitation. In July 2021, Reuters was given a first-hand demonstration of the possibilities wearable exoskeletons can have for people with disabilities.

Comments

Comentarios de Facebook

Subscribe to: Post Comments (Atom)